Abiopharma

Health In Tech Added to Membership of Russell Microcap® Index

Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer

Uxin Announces Closing of US$15 Million Investment from Parties Designated by NIO Capital under Previously Announced Share Subscription Agreements

Matador Resources Company Announces Expansion of San Mateo’s Delaware Basin Footprint Through the Acquisition of Cardinal Midstream

Rockwell Medical Announces 1-for-10 Reverse Stock Split

Constellium Sells Automotive Structures Joint Venture in Changchun, China

Philip Morris International and Maestro Andrea Bocelli Present “Believe. Further”

Korn Ferry Announces Definitive Agreement to Acquire AMS

Zymeworks to Acquire Theravance Biopharma, Inc.

THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT